HomeANVS • NYSE
add
Annovis Bio Inc
Previous close
$2.15
Day range
$2.02 - $2.16
Year range
$1.11 - $5.50
Market cap
59.55M USD
Avg Volume
391.04K
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 9.71M | 44.12% |
Net income | -9.83M | -67.69% |
Net profit margin | — | — |
Earnings per share | -0.39 | 9.30% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 19.53M | 85.11% |
Total assets | 21.08M | 51.39% |
Total liabilities | 4.23M | -8.39% |
Total equity | 16.85M | — |
Shares outstanding | 28.36M | — |
Price to book | 3.47 | — |
Return on assets | -126.81% | — |
Return on capital | -161.73% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -9.83M | -67.69% |
Cash from operations | -8.93M | -7.74% |
Cash from investing | — | — |
Cash from financing | 13.17M | 112.45% |
Net change in cash | 4.25M | 303.67% |
Free cash flow | -5.45M | 7.32% |
About
Founded
2008
Headquarters
Website
Employees
8
